Abstract:β-Defensins are cationic, antimicrobial peptides that participate in antimicrobial defense as well as the regulation of innate and adaptive immunity. Human β-defensin 126 (DEFB126) is a multifunctional glycoprotein consisting of a conserved β-defensin core and a unique long glycosylated peptide tail. The long glycosylated peptide tail has been proven to be critical for efficient transport of sperm in the female reproductive tract, preventing their immune recognition, and efficient delivery of capacitated sperm to the site of fertilization. However, the functions of the conserved β-defensin core remain to be fully elucidated. In the present work, the conserved β-defensin core of the DEFB126 was expressed to explore its potential antimicrobial and anti-inflammatory activities. The DEFB126 core peptide exhibited both high potency for binding and neutralizing lipopolysaccharide (LPS) in vitro, and potent anti-inflammatory ability by down-regulating the mRNA expression of pro-inflammatory cytokines including IL-α, IL-1β, IL-6 and TNF-α in a murine macrophage cell line RAW264.7. The treatment with the DEFB126 core peptide also led to correspondingly decreased secretion of IL-6 and TNF-α. The blockade of LPS-induced p42/44 and p38 MAPK signal pathway might contribute to the anti-inflammation effects of the DEFB126 core peptide. Furthermore, fluorescence-labeled DEFB126 could enter RAW 264.7 cells and reduce the production of LPS-stimulated inflammatory factors, implying that DEFB126 might also participate in intracellular regulation beyond its direct LPS neutralization. In summary, our results demonstrate that the DEFB 126 core peptide has critical functions in parallel to its C-terminal tail by showing LPS-binding activity, anti-inflammatory effects and intracellular regulatory function.

Production and characterization of recombinant human beta-defensin DEFB120.

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

High-level Production of Bioactive Human Beta-Defensin-4 in Escherichia Coli by Soluble Fusion Expression

Soluble expression and purification of human 8-defensin DEFB136 in<i> Escherichia</i><i> coli</i> and identification of its bioactivity

Soluble Fusion Expression and Characterization of Human Beta-Defensin 3 Using a Novel Approach.

Fusion Expression of Human β-Defensin DEFB113 and Its Biological Activities

Recent advances in the research and development of human defensins.

High-level Expression of Soluble Human Β-Defensin-2 in Escherichia Coli

Human Beta-Defensin DEFB126 is Capable of Inhibiting LPS-mediated Inflammation

Production Of Bioactive Human Beta-Defensin-3 In Escherichia Coli By Soluble Fusion Expression

The Novel Human Beta-Defensin 114 Regulates Lipopolysaccharide (Lps)-Mediated Inflammation And Protects Sperm From Motility Loss

Cloning and Expression of Human Beta-Defensin-2 Gene in Escherichia Coli

[Advances in the Research of Human Defensins].

The novel human β-defensin 114 regulates lipopolysaccharide (LPS)-mediated inflammation and protects sperm from motility loss.

Soluble fusion expression, characterization and localization of human β-defensin 6.

Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide

Efficient production of human beta-defensin 2 (HBD2) in Escherichia coli

An Improved Lentiviral System for Efficient Expression and Purification of Β‐defensins in Mammalian Cells

Preferential codons enhancing the expression level of human beta-defensin-2 in recombinant Escherichia coli.

Enhanced Expression and Primary Purification of Soluble HBD3 Fusion Protein in Escherichia coli

Production of Bioactive Human β -defensin-3 in Escherichia coli by Soluble Fusion Expression